Status:
COMPLETED
Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure
Lead Sponsor:
Wright State University
Conditions:
Respiratory Failure
Hypotension and Shock
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate whether protocolized vasopressor use for patients with normal blood pressure undergoing rapid sequence intubation improves hemodynamic parameters and mitiga...
Detailed Description
Aim: Prevent 25-46 percent reduction in systolic blood pressure associated with rapid sequence intubation with norepinephrine compared to isotonic fluids alone.
Eligibility Criteria
Inclusion
- Respiratory Failure Requiring Intubation
Exclusion
- Pregnancy
- Patients intubated during code blue clinical scenarios
- Requiring surgical airway
- Failed intubations
- MAP less than 65 or Systolic Blood Pressure (SBP) less than 90mmHg pre-intubation
- Systolic blood pressure greater than 150mmHg
- Prisoners
Key Trial Info
Start Date :
August 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05355974
Start Date
August 9 2022
End Date
July 10 2024
Last Update
July 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miami Valley Hospital Premier Health
Dayton, Ohio, United States, 45409